Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Company Overview - Seer, Inc. is a leading life sciences company focused on commercializing a new platform for proteomics, specifically the Proteograph Product Suite, which enables deep proteomic analysis at scale [7] - The company has achieved significant recognition, ranking No. 57 on the Deloitte Technology Fast 500 for 2024, with a remarkable revenue growth of 2,440% over the past three years [1][2] Revenue Growth - Seer's revenue growth of 2,440% is attributed to increased adoption of its Proteograph Product Suite and new discoveries by customers in areas such as neurodegenerative diseases, cancer, and metabolic diseases [2] - The average revenue growth for companies in the 2024 Technology Fast 500 was 1,981%, with a median growth rate of 460%, highlighting Seer's exceptional performance [4] Recent Developments - In 2024, Seer launched a technology access center in Europe and saw its Proteograph platform utilized by astronauts on the SpaceX Inspiration4 mission [3] - The company has entered into a co-marketing and sales agreement with Thermo Fisher Scientific, further validating its market position and technological advancements [3] Technology Fast 500 Criteria - To qualify for the Deloitte Technology Fast 500, companies must have proprietary intellectual property or technology that contributes to a majority of their operating revenues, with base-year revenues of at least $50,000 and current-year revenues of at least $5 million [6]